News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
22
2025
-
05
Lino Pharmaceuticals showcased its full matrix of products at the 2025 Guangzhou Pharmaceutical Fair, with its blockbuster new products demonstrating its strong capabilities!
Classification：
行业新闻
Corporate News
In the spring warmth of Guangzhou, by the Pearl River, the 90th National Pharmaceutical Trade Fair (2025 Pharmaceutical Fair) grandly opened on the 21st. The conference brought together many well-known pharmaceutical companies and experts and scholars from home and abroad to discuss the latest development trends and market dynamics of the pharmaceutical industry, and to enhance brand influence. Taking advantage of this grand event, Linyi Pharmaceutical, with its newly upgraded product matrix, was invited to exhibit, attracting many industry colleagues for discussions and exchanges.
Entering the Linyi Pharmaceutical 2.1G18 booth, a sense of technology and modernity came over you. The booth was bustling with people, with customers constantly coming to inquire and discuss. Linyi Pharmaceutical Chairman Li Hongfu and President Huang Fangsheng, led the marketing team in enthusiastically receiving each visitor, detailing the company's product advantages, R&D capabilities, market layout, and future development strategy.
Linyi Pharmaceutical exhibited its core classic products, covering several important areas such as cardiovascular, anti-diabetic, and central nervous systems. In addition, many recently launched new products also made their debut at this exhibition, attracting the attention of many industry experts and new and old partners. Among them, "Ferrous Protein Succinate Oral Solution" for the treatment of iron deficiency anemia, and children's cough medicine "Ambroxol Hydrochloride Droplets", Minoxidil Lotion, and Fudosteine Oral Solution, etc., attracted a lot of attention as soon as they were unveiled, winning high recognition and favor from customers, laying a solid foundation for the company's market expansion and in-depth layout.
It is worth mentioning that at the "Wuzhen Health Conference" which concluded in April, Linyi Pharmaceutical's new product "Ambroxol Hydrochloride Droplets" was honorably listed on the conference's "West Lake Award - The Most Popular Star Product among Retail Pharmacies". This honor is a high affirmation of the product's market value, and is also a powerful testament to the company's long-standing commitment to technology-driven, quality-first product philosophy.
Many partners at the exhibition said: "Linyi Pharmaceutical's increasingly complete product matrix has shown us the huge potential of Linyi Pharmaceutical in product expansion and layout, and has further strengthened our confidence in long-term cooperation with you." In the future, Linyi Pharmaceutical will continue to increase investment in new products, continuously optimize product structure, enrich product categories, and serve the public health with better and more comprehensive products.
Welcome everyone to visit booth 2.1G18 and win a new future with us!
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China